Medplus Health [MEDPLUS] vs Dipna Pharmachem [DPL] Detailed Stock Comparison

Medplus Health Services Ltd.

NSE
Loading...

Dipna Pharmachem Ltd.

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Medplus Health Services Ltd. wins in 10 metrics, Dipna Pharmachem Ltd. wins in 8 metrics, with 0 ties. Medplus Health Services Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Medplus Health Services Ltd. Dipna Pharmachem Ltd. Better
P/E Ratio (TTM) 52.45 10.09 Dipna Pharmachem Ltd.
Price-to-Book Ratio 5.89 0.35 Dipna Pharmachem Ltd.
Debt-to-Equity Ratio 64.69 23.42 Dipna Pharmachem Ltd.
PEG Ratio 1.08 N/A N/A
EV/EBITDA 28.75 8.55 Dipna Pharmachem Ltd.
Profit Margin (TTM) 3.17% 1.92% Medplus Health Services Ltd.
Operating Margin (TTM) 4.76% 2.34% Medplus Health Services Ltd.
EBITDA Margin (TTM) 4.76% 2.34% Medplus Health Services Ltd.
Return on Equity 8.64% 4.24% Medplus Health Services Ltd.
Return on Assets (TTM) 4.47% 1.59% Medplus Health Services Ltd.
Free Cash Flow (TTM) $4.81B $-92.15M Medplus Health Services Ltd.
Dividend Yield N/A 23.16% N/A
1-Year Return 0.15% -68.24% Medplus Health Services Ltd.
Price-to-Sales Ratio (TTM) 1.66 0.21 Dipna Pharmachem Ltd.
Enterprise Value $113.73B $338.55M Medplus Health Services Ltd.
EV/Revenue Ratio 1.74 0.32 Dipna Pharmachem Ltd.
Gross Profit Margin (TTM) 26.16% 44.45% Dipna Pharmachem Ltd.
Revenue per Share (TTM) $546 $45 Medplus Health Services Ltd.
Earnings per Share (Diluted) $17.28 $0.86 Medplus Health Services Ltd.
Beta (Stock Volatility) 0.46 -0.17 Dipna Pharmachem Ltd.

Medplus Health Services Ltd. vs Dipna Pharmachem Ltd. Stock Performance Analysis

Loading Price Chart...

MEDPLUS
DPL

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Medplus Health Services Ltd.-1.28%2.21%-8.44%5.44%7.75%7.41%
Dipna Pharmachem Ltd.2.00%-10.08%-4.80%-24.84%-48.60%-58.61%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Medplus Health Services Ltd.0.15%10.40%-18.04%-18.04%-18.04%-18.04%
Dipna Pharmachem Ltd.-68.24%-97.06%-96.96%-92.04%-93.84%-93.84%

Performance & Financial Health Analysis: Medplus Health Services Ltd. vs Dipna Pharmachem Ltd.

MetricMEDPLUSDPL
Market Information
Market Cap i₹108.75B₹228.19M
Market Cap CategoryMid capSmall cap
10 Day Avg. Volume i203,00945,900
90 Day Avg. Volume i146,81551,200
Last Close₹870.70₹7.14
52 Week Range₹732.00 - ₹1,022.20₹6.66 - ₹25.66
% from 52W High-14.82%-72.17%
All-Time High₹1,343.00 (Jan 17, 2022)₹558.00 (Jan 29, 2024)
% from All-Time High-35.17%-98.72%
Growth Metrics
Quarterly Revenue Growth0.16%-0.20%
Quarterly Earnings Growth0.26%3.19%
Financial Health
Profit Margin (TTM) i0.03%0.02%
Operating Margin (TTM) i0.05%0.02%
Return on Equity (TTM) i0.09%0.04%
Debt to Equity (MRQ) i64.6923.42
Cash & Liquidity
Book Value per Share (MRQ)₹153.91₹24.62
Cash per Share (MRQ)₹41.85₹0.29
Operating Cash Flow (TTM) i₹2.69B₹-140,640,000
Levered Free Cash Flow (TTM) i₹1.50B₹-160,558,752
Dividends
Last 12-Month Dividend Yield iN/A23.16%
Last 12-Month Dividend iN/A₹5.00

Valuation & Enterprise Metrics Analysis: Medplus Health Services Ltd. vs Dipna Pharmachem Ltd.

MetricMEDPLUS (Apr 24, 2026)DPL (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i52.4510.09
Forward P/E i44.24N/A
PEG Ratio i1.08N/A
Price to Sales (TTM) i1.660.21
Price to Book (MRQ) i5.890.35
Market Capitalization
Market Capitalization i₹108.75B₹228.19M
Enterprise Value i₹113.73B₹338.55M
Enterprise Value Metrics
Enterprise to Revenue i1.740.32
Enterprise to EBITDA i28.758.55
Risk & Other Metrics
Beta i0.46-0.17
Book Value per Share (MRQ) i₹153.91₹24.62

Financial Statements Comparison: Medplus Health Services Ltd. vs Dipna Pharmachem Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMEDPLUS (2025)DPL (2025)
Revenue/Sales i60.87B1.25B
Cost of Goods Sold i46.41B1.14B
COGS % of Revenue i76.2%91.0%
Gross Profit i14.47B111.90M
Gross Margin i23.8%9.0%
Research & Development iN/AN/A
Operating Income (EBIT) i2.39B40.07M
Operating Margin i3.9%3.2%
EBITDA i5.29B38.19M
EBITDA Margin i8.7%3.1%
Pre-Tax Income i1.83B14.20M
Pre-Tax Income % of Revenue i3.0%1.1%
Income Tax i330.56M4.47M
Income Tax % of Revenue i0.5%0.4%
Net Income (Profit) i1.50B9.73M
Profit Margin i2.5%0.8%

Balance Sheet & Liquidity Metrics

MetricMEDPLUS (2025)DPL (2025)
Cash & Equivalents i860.52M4.26M
Total Current Assets i18.44B1.32B
Total Current Assets % of Revenue i30.3%105.9%
Total Current Liabilities i5.77B849.96M
Total Current Liabilities % of Revenue i9.5%68.0%
Long-Term Debt i10.08B88.90M
Long-Term Debt % of Revenue i16.6%7.1%
Total Shareholders Equity i17.40B384.93M
Retained Earnings i4.30B31.22M
Retained Earnings % of Revenue i7.1%2.5%
Property, Plant & Equipment i12.49B489,000

Cash Flow Statement Comparison

MetricMEDPLUS (2025)DPL (2025)
Operating Cash Flow i2.69B-92.83M
Operating Cash Flow % of Revenue i4.4%-7.4%
Capital Expenditures i-584.02M-201,000
Free Cash Flow i4.81B-92.15M
FCF Margin i7.9%-7.4%
Debt Repayment iN/A-36.57M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricMEDPLUSDPL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i120.00M24.05M
Float Shares i69.60M11.37M
% Held by Insiders i41.74%51.68%
% Held by Institutions i35.32%0.00%
% Held by Public i22.94%48.32%

Dividend Analysis & Yield Comparison: Medplus Health Services Ltd. vs Dipna Pharmachem Ltd.

MetricMEDPLUSDPL
Last 12-Month Dividend iN/A₹5.00
Last 12-Month Dividend Yield iN/A23.16%
3-Year Avg Annual Dividend iN/A₹6.00
3-Year Avg Dividend Yield iN/A1.72%
3-Year Total Dividends iN/A₹18.00
Ex-Dividend DateN/AAug 13, 2024